The plasmid-mediated fosfomycin resistance determinants and synergy of fosfomycin and meropenem in carbapenem-resistant Klebsiella pneumoniae isolates in Taiwan

Journal of Microbiology, Immunology and Infection

Volumn 50, Issue 5, 2017, Pages 653-661

  Tseng, Sung Pin ^a,b   Wang, Sheng Fan ^a   Ma, Ling ^c   Wang, Ting Yin ^a   Yang, Tsung Ying ^a   Siu, L Kristopher ^c   Chuang, Yin Ching ^d   Lee, Pei Shan ^e   Wang, Jann Tay ^f   Wu, Tsu Lan ^g   Lin, Jung Chung ^h   Lu, Po Liang ^a,e,i  

^a KAOHSIUNG MEDICAL UNIVERSITY   (Taiwan)

^b NATIONAL SUN YAT SEN UNIVERSITY   (Taiwan)

^c NATIONAL HEALTH RESEARCH INSTITUTES   (Taiwan)

^d CHI MEI MEDICAL CENTER   (Taiwan)

^e KAOHSIUNG MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

^f NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

^g CHANG GUNG MEMORIAL HOSPITAL   (Taiwan)

^h TRI SERVICE GENERAL HOSPITAL   (Taiwan)

ⁱ KAOHSIUNG MEDICAL UNIVERSITY   (Taiwan)

Author keywords

blaKPC 2; Carbapenem resistance; fosA3; Fosfomycin; foskp96

Indexed keywords

BACTERIAL ENZYME; CARBAPENEMASE; FOSFOMYCIN; FOSFOMYCINASE; MEROPENEM; UNCLASSIFIED DRUG; BACTERIAL DNA; BACTERIAL PROTEIN; BETA LACTAMASE; BETA-LACTAMASE KPC-2, KLEBSIELLA PNEUMONIAE; THIENAMYCIN DERIVATIVE;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL GENE; BACTERIUM ISOLATE; CARBAPENEM RESISTANT ENTEROBACTERIACEAE; CLONE; DNA FLANKING REGION; DRUG POTENTIATION; GENE SEQUENCE; GENOTYPE; HORIZONTAL GENE TRANSFER; KLEBSIELLA PNEUMONIAE; MULTILOCUS SEQUENCE TYPING; NONHUMAN; PLASMID; POLYMERASE CHAIN REACTION; PULSED FIELD GEL ELECTROPHORESIS; TAIWAN; CARBAPENEM-RESISTANT ENTEROBACTERIACEAE; DRUG EFFECT; GENETICS; HOSPITAL; HUMAN; ISOLATION AND PURIFICATION; KLEBSIELLA INFECTION; MICROBIAL SENSITIVITY TEST; MICROBIOLOGY; MOLECULAR EPIDEMIOLOGY; TRANSPOSON;

BACTERIAL PROTEINS; BETA-LACTAMASES; CARBAPENEM-RESISTANT ENTEROBACTERIACEAE; DNA TRANSPOSABLE ELEMENTS; DNA, BACTERIAL; DRUG RESISTANCE, BACTERIAL; DRUG SYNERGISM; FOSFOMYCIN; GENES, BACTERIAL; GENOTYPE; HOSPITALS; HUMANS; KLEBSIELLA INFECTIONS; KLEBSIELLA PNEUMONIAE; MICROBIAL SENSITIVITY TESTS; MOLECULAR EPIDEMIOLOGY; MULTILOCUS SEQUENCE TYPING; PLASMIDS; TAIWAN; THIENAMYCINS;

EID: 85021994129     PISSN: 16841182     EISSN: 19959133     Source Type: Journal    
DOI: 10.1016/j.jmii.2017.03.003     Document Type: Article

References (37)

1. Gupta, N., Limbago, B.M., Patel, J.B., Kallen, A.J., Carbapenem-resistant Enterobacteriaceae: epidemiology and prevention. Clin Infect Dis 53 (2011), 60–67.
2. Kumarasamy, K.K., Toleman, M.A., Walsh, T.R., Bagaria, J., Butt, F., Balakrishnan, R., et al. Emergence of a new antibiotic resistance mechanism in India, Pakistan, and the UK: a molecular, biological, and epidemiological study. Lancet Infect Dis 10 (2010), 597–602.
3. Pitout, J.D., Nordmann, P., Poirel, L., Carbapenemase-producing Klebsiella pneumoniae: a key pathogen set for global nosocomial dominance. Antimicrob Agents Chemother 59 (2015), 5873–5884.
4. Falagas, M.E., Kastoris, A.C., Kapaskelis, A.M., Karageorgopoulos, D.E., Fosfomycin for the treatment of multidrug-resistant, including extended-spectrum beta-lactamase producing, Enterobacteriaceae infections: a systematic review. Lancet Infect Dis 10 (2010), 43–50.
5. Raz, R., Fosfomycin: an old–new antibiotic. Clin Microbiol Infect 18 (2012), 4–7.
6. Honderlick, P., Cahen, P., Gravisse, J., Vignon, D., Uncomplicated urinary tract infections, what about fosfomycin and nitrofurantoin in 2006?. Pathol Biol 54 (2006), 462–466.
7. Tseng, S.P., Wang, S.F., Kuo, C.Y., Huang, J.W., Hung, W.C., Ke, G.M., et al. Characterization of fosfomycin resistant extended-spectrum β-lactamase-producing Escherichia coli isolates from human and pig in Taiwan. PLoS One, 10, 2015, e0135864.
8. Ho, P.L., Chan, J., Lo, W.U., Lai, E.L., Cheung, Y.Y., Lau, T.C., et al. Prevalence and molecular epidemiology of plasmid-mediated fosfomycin resistance genes among blood and urinary Escherichia coli isolates. J Med Microbiol 62 (2013), 1707–1713.
9. Lee, S.Y., Park, Y.J., Yu, J.K., Jung, S., Kim, Y., Jeong, S.H., et al. Prevalence of acquired fosfomycin resistance among extended-spectrum β-lactamase-producing Escherichia coli and Klebsiella pneumoniae clinical isolates in Korea and IS26-composite transposon surrounding fosA3. J Antimicrob Chemother 67 (2012), 2843–2847.
10. Sato, N., Kawamura, K., Nakane, K., Wachino, J., Arakawa, Y., First detection of fosfomycin resistance gene fosA3 in CTX-M-producing Escherichia coli isolates from healthy individuals in Japan. Microb Drug Resist 19 (2013), 477–482.
11. Clinical and Laboratory Standards Institute, Performance standards for antimicrobial susceptibility testing. Twenty-fifth informational supplement. Document M100-S25 Wayne, PA. 2015, CLSI.
12. Ma, L., Lu, P.L., Siu, L.K., Hsieh, M.H., Molecular typing and resistance mechanisms of imipenem-non-susceptible Klebsiella pneumoniae in Taiwan: results from the Taiwan surveillance of antibiotic resistance (TSAR) study, 2002-2009. J Med Microbiol 62 (2013), 101–107.
13. IMP-8 in Raoultella planticola. Antimicrob Agents Chemother 58 (2014), 593–595.
14. Ma, Y., Xu, X., Guo, Q., Wang, P., Wang, W., Wang, M., Characterization of fosA5, a new plasmid-mediated fosfomycin resistance gene in Escherichia coli. Lett Appl Microbiol 60 (2015), 259–264.
15. Evren, E., Azap, O.K., Colakoglu, S., Arslan, H., In vitro activity of fosfomycin in combination with imipenem, meropenem, colistin and tigecycline against OXA 48-positive Klebsiella pneumoniae strains. Diagn Microbiol Infect Dis 76 (2013), 335–338.
16. White, R.L., Burgess, D.S., Manduru, M., Bosso, J.A., Comparison of three different in vitro methods of detecting synergy: time-kill, checkerboard, and E test. Antimicrob Agents Chemother 40 (1996), 1914–1918.
17. Chang, E.K., Kao, K.L., Tsai, M.S., Yang, C.J., Huang, Y.T., Liu, C.Y., et al. Occult Klebsiella pneumoniae bacteremia at emergency department: a single center experience. J Microbiol Immunol infect 48 (2015), 684–691.
18. Lin, W.H., Tseng, C.C., Wu, A.B., Yang, D.C., Cheng, S.W., Wang, M.C., et al. Clinical and microbiological characteristics of peritoneal dialysis-related peritonitis caused by Klebsiella pneumoniae in southern Taiwan. J Microbiol Immunol infect 48 (2015), 276–283.
19. Wu, P.F., Chang, Y.Y., Lin, Y.T., Wang, F.D., Chan, Y.J., Fung, C.P., Clinical characteristics and economic consequence of Klebsiella pneumoniae liver abscess in Taiwan. J Microbiol Immunol infect 48 (2015), 190–197.
20. Yang, H.S., Fang, W.L., Lin, Y.T., A case of liver abscess caused by tigecycline-nonsusceptible Klebsiella pneumoniae. J Microbiol Immunol infect 49 (2016), 621–622.
21. KPC-2 from Brazil. J Infect 67 (2013), 247–249.
22. Kaase, M., Szabados, F., Anders, A., Gatermann, S.G., Fosfomycin susceptibility in carbapenem-resistant Enterobacteriaceae from Germany. J Clin Microbiol 52 (2014), 1893–1897.
23. Jiang, Y., Shen, P., Wei, Z., Liu, L., He, F., Shi, K., et al. Dissemination of a clone carrying a fosA3-harbouring plasmid mediates high fosfomycin resistance rate of KPC-producing Klebsiella pneumoniae in China. Int J Antimicrob Agents 45 (2015), 66–70.
24. KPC-containing Klebsiella pneumoniae isolates, including those nonsusceptible to tigecycline and/or colistin. Antimicrob Agents Chemother 54 (2010), 526–529.
25. Ho, P.L., Chan, J., Lo, W.U., Law, P.Y., Li, Z., Lai, E.L., et al. Dissemination of plasmid-mediated fosfomycin resistance fosA3 among multidrug-resistant Escherichia coli from livestock and other animals. J Appl Microbiol 114 (2013), 695–702.
26. CTX-M-24 from Klebsiella pneumoniae. J Antimicrob Chemother 62 (2008), 1252–1256.
27. Chen, Y.T., Lin, J.C., Fung, C.P., Lu, P.L., Chuang, Y.C., Wu, T.L., et al. KPC-2-encoding plasmids from Escherichia coli and Klebsiella pneumoniae in Taiwan. J Antimicrob Chemother 69 (2014), 628–631.
28. Yu, W.L., Lee, M.F., Tang, H.J., Chang, M.C., Walther-Rasmussen, J., Chuang, Y.C., Emergence of KPC new variants (KPC-16 and KPC-17) and ongoing outbreak in southern Taiwan. Clin Microbiol Infect, 21, 2015 347 e5–8.
29. Van Hoek, A.H., Mevius, D., Guerra, B., Mullany, P., Roberts, A.P., Aarts, H.J., Acquired antibiotic resistance genes: an overview. Front Microbiol, 2, 2011, 203.
30. SHV-12, and rmtB from an epidemic Klebsiella pneumoniae sequence type 11 strain in China. Antimicrob Agents Chemother 60 (2015), 1343–1348.
31. KPC-2 by the spread of Klebsiella pneumoniae clonal complex 258 clones (ST258, ST11, ST437) and plasmids (IncFII, IncN, IncL/M) among Enterobacteriaceae species in Brazil. Antimicrob Agents Chemother 55 (2011), 3579–3583.
32. Damjanova, I., Toth, A., Paszti, J., Hajbel-Vekony, G., Jakab, M., Berta, J., et al. Expansion and countrywide dissemination of ST11, ST15 and ST147 ciprofloxacin-resistant CTX-M-15-type beta-lactamase-producing Klebsiella pneumoniae epidemic clones in Hungary in 2005–the new ‘MRSAs’?. J Antimicrob Chemother 62 (2008), 978–985.
33. Ko, K.S., Lee, J.Y., Baek, J.Y., Suh, J.Y., Lee, M.Y., Choi, J.Y., et al. Predominance of an ST11 extended-spectrum beta-lactamase-producing Klebsiella pneumoniae clone causing bacteraemia and urinary tract infections in Korea. J Med Microbiol 59 (2010), 822–828.
34. Chiu, S.K., Wu, T.L., Chuang, Y.C., Lin, J.C., Fung, C.P., Lu, P.L., et al. National surveillance study on carbapenem non-susceptible Klebsiella pneumoniae in Taiwan: the emergence and rapid dissemination of KPC-2 carbapenemase. PLoS One, 8, 2013, e69428.
35. Yang, J., Ye, L., Guo, L., Zhao, Q., Chen, R., Luo, Y., et al. A nosocomial outbreak of KPC-2-producing Klebsiella pneumoniae in a Chinese hospital: dissemination of ST11 and emergence of ST37, ST392 and ST395. Clin Microbiol Infect 19 (2013), E509–E515.
36. Souli, M., Galani, I., Boukovalas, S., Gourgoulis, M.G., Chryssouli, Z., Kanellakopoulou, K., et al. In vitro interactions of antimicrobial combinations with fosfomycin against KPC-2-producing Klebsiella pneumoniae and protection of resistance development. Antimicrob Agents Chemother 55 (2011), 2395–2397.
37. Samonis, G., Maraki, S., Karageorgopoulos, D.E., Vouloumanou, E.K., Falagas, M.E., Synergy of fosfomycin with carbapenems, colistin, netilmicin, and tigecycline against multidrug-resistant Klebsiella pneumoniae, Escherichia coli, and Pseudomonas aeruginosa clinical isolates. Eur J Clin Microbiol Infect Dis 31 (2012), 695–701.